France
Case Report
Gemcitabine and Hemolytic Uremic Syndrome: a Case Report
Author(s): Villalba NL, Merzouki T, González NS, Ortiz MBA, Kechida M, Bailon MM, Zamorano NF, Saint-Mezard V and Teguo MTVillalba NL, Merzouki T, González NS, Ortiz MBA, Kechida M, Bailon MM, Zamorano NF, Saint-Mezard V and Teguo MT
We are reporting the case of a 61 year old male patient with a medical history of pancreatic cancer on chemotherapy presenting a uremic hemolytic syndrome after the administration of gemcitabine. The renal function progressively worsened during his stay in spite of general measures and steroids, leading to the death at day 12 of admission... Read More»
DOI:
10.4172/2165-7831.1000168
Journal of Blood & Lymph received 443 citations as per Google Scholar report